Cannabinoids: from pot to lab
Esther Papaseit, Clara Pérez‐mañá, A. P. Pérez-Acevedo, Olga Hladun, M. C. Torres-Moreno, Roberto Muga, Marta Torrens, M. Farré
International Journal of Medical Sciences August 6, 2018 DOI: 10.7150/ijms.27087 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | The review describes how distinctions between natural and synthetic cannabinoids and between recreational and medical use have become blurred, and surveys legal changes, shifting cannabis composition and consumption patterns, the concept of medical cannabis, and synthetic cannabinoids as new psychoactive substances. It also examines serious adverse reactions and intoxications associated with synthetic cannabinoids and recent developments in pharmaceutical cannabinoid research. |
Abstract
Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. In this paper we review some of the novel aspects of cannabis and cannabinoids in relation to their legal situation, changes in their composition and forms of cannabis use, the concept of medical cannabis, and synthetic cannabinoids as new psychoactive substances (NPS). We have also analyzed serious adverse reactions and intoxications associated with the use of synthetic cannabinoids, as well as the latest developments in the research of pharmaceutical cannabinoids.
Citations in the library
Cited by 7
- Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence International Journal of Molecular Sciences May 15, 2022
- Delta-8-THC association with psychosis: A case report with literature review Frontiers in Psychiatry February 20, 2023
- Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users Biology March 24, 2021
- Pediatric Brain on Cannabinoids: Adverse Effects of Cannabinoid Products in Children and Adolescents IntechOpen eBooks August 3, 2022
- Decoding the Toxicity of Synthetic Cannabinoids: From Receptor Activation to Multiorgan Dysfunction. Medicinal Research Reviews June 24, 2026
and 2 more in the library
Cites 7
- Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis World Psychiatry September 22, 2016
- Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study British Journal of Pharmacology November 22, 2017
- The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review Brain Sciences February 27, 2018
- Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study. Clinical Toxicology September 1, 2016
- Fatal intoxication with synthetic cannabinoid MDMB-CHMICA. Forensic Science International April 1, 2016
and 2 more in the library